Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe
|更新时间:2025-12-15
|
Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe
“In the field of medical imaging, researchers have successfully constructed a PET probe 68Ga-THP-ACN376 targeting CLDN18.2, which has high labeling efficiency and stability, providing a new method for detecting CLDN18.2 protein expression.”
Chang LIU, Yuwen YANG, Zhi YANG, et al. Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe[J]. Oncoradiology, 2025, 34(5): 470-476.
DOI:
Chang LIU, Yuwen YANG, Zhi YANG, et al. Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe[J]. Oncoradiology, 2025, 34(5): 470-476. DOI: 10.19732/j.cnki.2096-6210.2025.05.005.
Site-specific development and preclinical evaluation of 68Ga-THP-ACN376, a CLDN18.2-targeted nanobody probe